Prostate Cancer Research
The Urologic Oncology Program investigators participate in the Prostate Cancer Foundation's Clinical Research Consortium.
The consortium ensures that leading cancer centers maintain a robust infrastructure for conducting prostate cancer clinical trials. The U-M Rogel Cancer Center is one of eight leading prostate cancer programs that form the consortium. Together, these institutions collaborate to rapidly and efficiently develop promising prostate cancer therapies. To date, Prostate Cancer Foundation has provided more than $17 million to this effort. More information on this and other initiatives can be found on their www.prostatecancerfoundation.org.